Postdoctoral Fellow – Cardiovascular – The University of Newcastle Australia

Expressions of interest are now open for a postdoctoral fellow within the Cardiovascular research program.


The postdoctoral research scholar will be focused on developing and translating therapeutic methodologies for the management and mitigation of cancer treatment-related cardiotoxicity, specifically LV remodelling. The research will be conducted in vitro by using model cell systems and in vivo with animal models.

The postdoctoral fellow is not only expected to apply existing technologies, but also investigate therapeutic mechanism for next generation therapeutic development. The research investigation will cover routine molecular biology, biochemistry, physiological and histological evaluations, but also cloning and genetically modified cell lines and animals.

The postdoctoral fellow will design and optimize research plans for the projects, develop new research techniques and protocols, analyze and prepare results for publications, present research at lab meetings, and prepare manuscripts for international conference presentations. Additional duties will include supervising and mentoring undergraduate and graduate students.

QUALIFICATIONS (Education & Experience):

Minimum Qualifications:
Doctoral degree from an accredited institution and appropriate experience and training within a selected area of specialization. Must meet university criteria for appointment to the rank of Postdoctoral Fellow.

Preferred Qualifications:
It is preferred that the candidate have experience with primary cell isolations and cloning/transfection. It is also preferred that the candidate have excellent verbal and written communication skills. Experience with animal work and surgery is an advantage.


The successful applicant will be appointed at Academic Level A* 1.0 FTE for a duration of two years, with the possibility of an extension.

Please send your CV and any position enquiries to:

A/Prof Doan Ngo –

A/Prof Aaron Sverdlov –

The EOI will close Friday 8th September 2017.